BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (www.saladax.com) has executed an exclusive distribution agreement with FALCO SD HOLDINGS Co., Ltd. of Kyoto, Japan for the Saladax My-5-FU MYCARE™ test kit in the Japanese market. The My-5-FU blood test enables oncologists to determine the precise amount of 5-fluorouracil (5-FU) chemotherapy in a patient’s blood, allowing them to administer an accurate dose to each patient.
